Used in pharmaceutical research as a key intermediate in the synthesis of selective serotonin reuptake inhibitors (SSRIs) and other central nervous system active compounds. Its structure supports binding to neurotransmitter receptors, making it valuable in developing antidepressants and anxiolytic agents. The compound’s amine and ether functionalities allow for easy modification, enabling the creation of derivative molecules for structure-activity relationship studies. It is also employed in the development of radiolabeled analogs for receptor binding assays and neuroimaging applications.